Singular Genomics Systems (OMIC) Short Interest Ratio & Short Volume

Short interest is the volume of Singular Genomics Systems shares that have been sold short but have not yet been covered or closed out. As of January 31st, investors have sold 44,800 shares of OMIC short. 2.91% of Singular Genomics Systems' shares are currently sold short. Learn More on Singular Genomics Systems' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OMIC shares currently have a short interest ratio of 3.0. Learn More on Singular Genomics Systems's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Singular Genomics Systems: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.91% of Singular Genomics Systems' floating shares are currently sold short.

Singular Genomics Systems saw a drop in short interest in January. As of January 31st, there was short interest totaling 44,800 shares, a drop of 1.3% from the previous total of 45,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Singular Genomics Systems currently has issued a total of 2,540,000 shares. Some of Singular Genomics Systems' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Singular Genomics Systems currently has a public float of 1,540,000 shares.

2.91% of Singular Genomics Systems' shares are currently sold short. Here is how the short interest of companies in the industry of "measuring and control equipment" compare to Singular Genomics Systems: Nautilus Biotechnology, Inc. (0.49%), Kewaunee Scientific Co. (2.90%), Frequency Electronics, Inc. (0.17%), Seer, Inc. (5.52%), Rapid Micro Biosystems, Inc. (0.68%), Akoya Biosciences, Inc. (15.76%), 908 Devices Inc. (8.99%), Owlet, Inc. (4.24%), Prenetics Global Limited (0.48%), Syntec Optics Holdings, Inc. (0.43%),

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks.

Short selling OMIC is an investing strategy that aims to generate trading profit from Singular Genomics Systems as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Singular Genomics Systems occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of OMIC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OMIC, twice per month. The most recent reporting period available is January, 31 2025.